Fig. 4
From: MiRNA-149 modulates chemosensitivity of ovarian cancer A2780 cells to paclitaxel by targeting MyD88
Cell cycle analysis of A2780 cells treated with paclitaxel in relation to miRNA-149 down-regulation. a Flow cytometric analysis of the cell cycle with miRNA-149-down-regulated and control cells. b G2 phase analysisof the cell cycle with miRNA-149-down-regulated and control cells. c Quantitative analysis of the fold change of the G2 phase ratio after paclitaxel treatment in A2780 cells with down-regulation of miRNA-149. Fold change of G2 phase was calculated as: Fold change of G2 phase = G2 phase with paclitaxel treatment/G2 phase without paclitaxel treatment